- Home
- INVA vs GAM Comparison
INVA vs GAM Comparison
Compare INVA & GAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$21.34
Company Overview
Basic Information| Metric | INVA | GAM |
|---|---|---|
| Founded | 1996 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | INVA | GAM |
|---|---|---|
| Price | $21.34 | $66.39 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 542.7K | 11.8K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.74% |
| EPS Growth | ★ 816.67 | N/A |
| EPS | 1.25 | ★ 11.67 |
| Revenue | ★ $217,217,000.00 | N/A |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $12.65 | N/A |
| P/E Ratio | $17.06 | ★ $5.70 |
| Revenue Growth | ★ 62.63 | N/A |
| 52 Week Low | $16.52 | $56.24 |
| 52 Week High | $25.15 | $68.57 |
Technical Indicators
Market Signals| Indicator | INVA | GAM |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 49.45 |
| Support Level | $21.42 | $62.30 |
| Resistance Level | $21.91 | $68.43 |
| Average True Range (ATR) | 0.35 | 0.85 |
| MACD | 0.08 | -0.22 |
| Stochastic Oscillator | 76.26 | 27.90 |
Price Performance
Historical Comparison INVA
GAM
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
About GAM General American Investors Inc.
General American Investors Co Inc is a closed-end, diversified management investment company. It manages a portfolio of investments, consisting of common stocks of U.S. companies, as well as international and private securities.